4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FDMT | VERV | AMLX | ||
| Company | 4D Molecular Therapeutics Inc | Verve Therapeutics Inc | Amylyx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.41 | 4.55 | 5.23 | ||
| High | 8.48 | 4.69 | 5.42 | ||
| Low | 7.82 | 4.44 | 4.98 | ||
| Last | 7.99 | 4.60 | 5.19 | ||
| Change | -0.42 | +0.05 | -0.04 | ||
| % Change | -4.99% | +1.10% | -0.76% | ||
| Volume | 942,800 | 1,398,100 | 1,889,300 | ||
| 20-Day Average Volume | 803,835 | 1,654,195 | 1,693,395 | ||
| Previous Close | 8.41 | 4.55 | 5.23 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.23 | 5.71 | 5.63 | ||
| 20-Day Raw Stochastic | 36.02% | 6.75% | 22.96% | ||
| 20-Day Relative Strength | 38.51% | 38.83% | 54.09% | ||
| Weighted Alpha | -49.31 | -61.76 | +114.82 | ||
| Today's Opinion | 96% Sell | 72% Sell | 64% Buy | ||
| Previous Opinion | 80% Sell | 72% Sell | 64% Buy | ||
| Last Month's Opinion | 100% Sell | 56% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.37% since 11/14/24 | -14.50% since 11/14/24 | +3.39% since 11/14/24 | ||
| Low | 7.82 on 11/21/24 | 4.44 on 11/21/24 | 4.57 on 11/15/24 | ||
| High | 9.18 on 11/18/24 | 5.44 on 11/15/24 | 5.88 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -6.88% since 10/21/24 | -17.12% since 10/21/24 | +11.37% since 10/21/24 | ||
| Low | 7.32 on 11/14/24 | 4.44 on 11/21/24 | 4.45 on 10/22/24 | ||
| High | 9.18 on 11/18/24 | 6.81 on 11/06/24 | 7.27 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | -47.40% since 08/21/24 | -10.16% since 08/21/24 | +129.65% since 08/21/24 | ||
| Low | 7.32 on 11/14/24 | 4.37 on 10/10/24 | 2.05 on 08/28/24 | ||
| High | 17.41 on 09/19/24 | 6.81 on 11/06/24 | 7.27 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | -68.23% since 05/21/24 | -16.97% since 05/21/24 | +188.33% since 05/21/24 | ||
| Low | 7.32 on 11/14/24 | 4.30 on 08/14/24 | 1.58 on 06/17/24 | ||
| High | 28.93 on 07/17/24 | 7.96 on 07/16/24 | 7.27 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 369,362 | 389,454 | 355,764 | ||
| Shares Outstanding, K | 46,228 | 84,664 | 68,548 | ||
| Annual Sales | 20,720,000 | 11,760,000 | 380,790,000 | ||
| Annual Net Income | -100,840,000 | -200,070,000 | 49,270,000 | ||
| Last Quarter Sales | 10,000 | 6,870,000 | 420,000 | ||
| Last Quarter Net Income | -34,950,000 | -50,130,000 | -72,700,000 | ||
| 60-Month Beta | 2.82 | 1.75 | -0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.79 on 11/13/24 | -0.59 on 11/05/24 | -0.53 on 11/07/24 | ||
| Latest Earnings Date | 11/14/24 | 11/05/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 03/28/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||